U.S. Healthtech Stock News

F5 (FFIV) drew fresh attention after expanding its partnership with Scality, linking F5’s Application Delivery and Security Platform to Scality’s S3 compatible object storage to support large scale AI and analytics workloads. See our latest analysis for F5. Despite the AI focused partnership news, F5’s share price of US$269.52 comes after a 12.3% 90 day share price return and a 3 year total shareholder return of 91.6%. This suggests that longer term momentum has been stronger than the recent...

Why Extra Space Storage Is Getting Attention Now Extra Space Storage (EXR) is drawing fresh interest after recent share moves, including a one-month return of about 6% and a past three-month gain of roughly 14%, prompting closer scrutiny of its fundamentals. See our latest analysis for Extra Space Storage. At around US$150.41, Extra Space Storage’s recent 7 day share price return of 2.77% and 90 day share price return of 13.63% suggest building momentum, even though the 1 year total...

Why Aflac (AFL) Is On Investors’ Radar Today Aflac (AFL) has drawn attention after recent trading left the stock roughly flat over the past 3 months but higher over the past month, prompting investors to reassess what they are paying for its insurance earnings. See our latest analysis for Aflac. At around $112 per share, Aflac’s recent 4.9% 1 month share price return sits against a much stronger backdrop, with a 1 year total shareholder return of 10.3% and 5 year total shareholder return of...

SPS Commerce (NasdaqGS:SPSC) has introduced MAX, a new suite of embedded AI tools aimed at improving supply chain operations. MAX is built into customers' existing workflows and is designed to monitor, guide, and automate processes across SPS Commerce's network. The release positions MAX as a differentiated AI offering focused on practical, day to day supply chain decision support. SPS Commerce, trading on NasdaqGS as SPSC, is rolling out MAX at a time when its shares are at $54.22 and...

Recent news around Nebius Group (NasdaqGS:NBIS) has centered on rising contracted power guidance, strong demand for its AI cloud services, ambitious 2026 revenue targets, and fresh momentum from major data center projects and customer wins. See our latest analysis for Nebius Group. The recent news flow around larger AI infrastructure contracts, raised contracted power guidance and the Tavily acquisition has coincided with building momentum, with a 30 day share price return of 6.47% and a 1...

In February 2026, Blue Planet announced that Lumen Technologies adopted its OSS-native AI Studio platform to deploy AI agents across multiple network domains, aiming to boost operational efficiency and customer experience while Lumen also expanded its enterprise portfolio with a Multi-Cloud Gateway and enhanced metro data-center connectivity for AI and hybrid workloads. These moves, combined with recent upgrades to Lumen’s credit ratings from all three major agencies, highlight a pivot...

Enpro Inc. reported past fourth-quarter 2025 sales of US$295.4 million and a net loss of US$32 million, issued 2026 revenue growth guidance of 8% to 12%, and signaled ongoing capacity for acquisitions under its Enpro 3.0 framework. The company is pairing a small quarterly dividend increase to US$0.32 per share with plans to pursue acquisitions that add technology, talent, and process expertise in its key growth areas. We’ll now examine how Enpro’s 2026 revenue guidance and acquisition...

If you are trying to figure out whether KKR is attractively priced or not, starting with a clear view of its current value story can help you frame your next move. KKR's share price recently closed at US$92.19, after a 9.4% decline over the last 7 days, a 24.0% decline over 30 days, a 28.5% decline year to date and a 29.3% decline over 1 year. Over longer periods, the 3 year and 5 year returns sit at 69.4% and 107.9% respectively. These moves have come alongside ongoing attention on global...

If you are wondering whether Performance Food Group's share price still offers value at around US$95.79, you are not alone. Many investors are asking the same question before making their next move. The stock has seen a 2.3% decline over the last 7 days, a 2.0% gain over 30 days, and is up 8.8% year to date, with a 15.6% return over 1 year, 65.2% over 3 years and 70.9% over 5 years. These figures may influence how you think about its risk and reward trade off. Recent company updates and...

Oklo (NYSE:OKLO) announced plans for a privately funded advanced nuclear fuel recycling facility intended to improve fuel use and reduce waste. The company is expanding into radioisotope production through its acquisition of Atomic Alchemy, targeting new commercial applications. Oklo also reported deeper partnerships with firms including Meta Platforms and Siemens Energy, aimed at broader adoption of its clean energy solutions. For investors watching NYSE:OKLO, these moves come as the stock...

In recent weeks, Hershey has been challenged by public claims from a Reese family member that Reese’s ingredients have been cheapened, which the company disputes, while also confronting softer unit sales, higher costs and pressure on operating margins. This clash between brand heritage concerns and evidence of less profitable incremental growth raises questions about how resilient Hershey’s product portfolio and pricing power really are. Next, we’ll examine how this ingredient controversy,...

Earlier in February 2026, Birkenstock Holding plc reported higher first-quarter sales of €401.9 million and net income of €50.56 million, reaffirmed its full-year 2026 guidance, outlined plans to open about 40 new own-retail stores, and said its Board will consider a potential share repurchase program. Taken together with easing tariff pressures and a continued push into closed shoes, these moves highlight Birkenstock’s focus on controlled expansion, brand stewardship, and potentially more...

What recent performance says about Novavax (NVAX) Novavax (NVAX) has quietly posted mixed share performance recently, with a 1 day return of 1.7%, a 7 day move of 7.6%, and gains over the past month and past 3 months. For longer term holders the picture is different, with a 1 year total return of 26.3%, around 8% over 3 years, and a much weaker 5 year outcome, which may influence how you frame risk and expectations. See our latest analysis for Novavax. At a share price of $9.36, Novavax has...

Allegiant Travel (ALGT) has drawn fresh attention after unveiling Flight #925, a themed Orlando to Knoxville route created with Dollywood Parks & Resorts. The offering pairs air travel with exclusive theme park, entertainment, and lodging perks. See our latest analysis for Allegiant Travel. The latest Flight #925 announcement comes after a stretch of strong momentum in Allegiant Travel’s share price, with a 43% 90 day share price return and 27.06% 1 year total shareholder return, contrasted...

Recent performance snapshot Ciena (CIEN) has attracted fresh attention after a strong share price move over the past month, with a return of about 50%, and roughly 76% over the past 3 months. This has prompted investors to reassess the stock. See our latest analysis for Ciena. That surge comes on top of a 40.1% year to date share price return and a very large 1 year total shareholder return. Together, these point to strong recent momentum and a meaningful shift in how the market is pricing...

If you are looking at Perrigo and wondering whether the recent share price reflects its true worth, this article will walk you through what the numbers are saying about value. The stock closed at US$14.55, with returns of 0.1% over 7 days, a 1.2% decline over 30 days, 4.8% year to date, and declines of 39.1% over 1 year, 54.5% over 3 years, and 58.8% over 5 years, which can change how investors see both risk and upside potential. Recent news coverage around Perrigo has focused on its...

KB Home (KBH) is back in focus after analysts flagged that upcoming results are expected to show weaker revenue and earnings versus last year, with recent estimate changes appearing to weigh more heavily on the stock. See our latest analysis for KB Home. At a share price of US$64.36, KB Home has seen a 9.01% 1 month share price return and a 12.77% year to date share price return. The 3 year total shareholder return of 90.48% contrasts with softer recent moves as analysts focus on potentially...

Recent share performance context for TransDigm Group Recent price moves in TransDigm Group (TDG) have drawn investor attention, with the stock showing mixed returns across different periods and prompting closer scrutiny of its fundamentals and valuation. See our latest analysis for TransDigm Group. The recent pullback, with a 1 month share price return of an 8.67% decline and a year to date share price return of a 4.59% decline from US$1,296.15, contrasts with a 1 year total shareholder...

Earlier in 2026, Trump Media & Technology Group saw its post-merger trading momentum weaken as the stock slipped to new lows amid shifting market sentiment and technical pressure. Traders have highlighted fading short interest, increasingly bearish option positioning, and mixed insider transactions as key signals shaping how investors interpret the company’s public-market debut phase. We’ll now examine how the combination of bearish trading setups and recent insider activity may influence...

If you are wondering whether Okta's share price today reflects its true worth, you are not alone. This article will walk through how the current market view compares with several common valuation checks. Okta's share price closed at US$69.51, with returns of 20.3% decline over 7 days, 23.4% decline over 30 days, 16.9% decline year to date, 23.5% decline over 1 year, 3.0% decline over 3 years, and 74.2% decline over 5 years. These moves may have shifted how investors think about its risk and...

Wendy's (WEN) is back in focus after management paired cautious 2026 guidance, including flat global systemwide sales, with plans to close 5% to 6% of U.S. stores and rising pressure from activist Trian Partners. See our latest analysis for Wendy's. At a share price of US$7.77, Wendy's has seen a 3.9% one day share price decline and a 7.8% 90 day share price return decline, while the 1 year total shareholder return is down 48.3%. This suggests that recent activist headlines and cautious...

NewAmsterdam Pharma Company N.V. reported past full-year 2025 results on February 18, showing sales of US$22.5 million and a net loss of US$203.82 million, while also filing an omnibus shelf registration for up to 5,719,966 common shares. Despite lower revenue and continued losses, analysts highlighted management’s confidence in obicetrapib’s late-stage trials and regulatory path, underscoring its central role in the company’s future. We’ll now examine how confidence in obicetrapib’s...

In February 2026, Bank of America Corporation completed and announced multiple senior unsecured bond offerings across maturities from 2027 to 2046 totaling several hundred million US dollars, while also unveiling a new Art Consulting service for wealth clients and deepening its data partnership with London Stock Exchange Group. Together with a US$25.00 billion commitment to private-credit deals, these moves highlight Bank of America’s push to broaden fee and interest income sources across...

If you are wondering whether Kirby's current share price truly reflects its underlying value, you are not alone. That is exactly what this article will unpack. With the stock at US$128.46 after a 2.8% gain over the last 7 days, a flat 0.2% move over 30 days, and returns of 14.8% year to date, 27.3% over 1 year, 76.4% over 3 years and 100.0% over 5 years, many investors are asking what is already priced in. Recent attention on Kirby has largely centered on its role in the U.S. marine...